Replies to post #1224 on Argos Therapeutics Inc fka ARGSQ

[TheShadow]

Of course there is no smoking gun proof!
Remember the CC that was rescheduled?
Remember all the PR's prior to the CC?
Trading OTC tickers gave me a better understanding of these things!

Argos today also reported that it has raised approximately $6.8 million of net proceeds under its at-the-market stock issuance facility with Cowen & Company subsequent to the close of the third quarter on September 30, 2017. The Company also announced that it has entered into a satisfaction and release agreement with one of its principal vendors, pursuant to which the Company restructured a $4.0 million deferred payment obligation by issuing an unsecured amortizing convertible note with a maturity date of September 30, 2020 in the approximate amount of $2.4 million, transferring ownership to the vendor of certain equipment developed by the vendor for Argos and valued at approximately $1.0 million, and making a payment of approximately $0.6 million as a combination of cash and common stock.

https://ih.advfn.com/p.php?pid=nmona&article=76181118